Heterodimeric cytokine that can promote Th1-type helper T cell development, induces interferon-gamma, and facilitate T cell cytotoxic responses and increases NK cell lytic activity.
In addition to pegylated liposomal doxirubicin in patients with Kaposi’s sarcoma requiring chemotherapy revealed a 25% complete remission rate.